Prednisolone does not improve olfactory function after COVID-19, finds a study published in BMCMedicine
Since many patients suffer from olfactory disorders after COVID-19, we need to ensure the effectiveness of this treatment. Therefore, we investigated the efficacy of a treatment in combination with olfactory training in a randomized, double-blind, placebo-controlled, single-centered trial.
We collected further baseline characteristics such as vaccination status and COVID-19 symptoms at first visit. Furthermore, we performed a nasendoscopy in order to eliminate other causes for olfactory disorders. Patients underwent objective smell and taste tests, and filled in three additional questionnaires. At the baseline visit, patients received their randomly allocated blinded study medication and were instructed to start their 10 days of study medication the next morning.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
China’s response to a surge in covid-19 cases is muddledIn all, areas producing a fifth of China’s GDP are now under some form of lockdown, according to Nomura, a bank
Lire la suite »
Intensive care delirium: 'I hallucinated that I'd been kidnapped'Jan Ehtash endured strange and unsettling visions as she battled Covid in a south London hospital.
Lire la suite »
The potential of Sofosbuvir against COVID-19 neurological symptomsThe potential of Sofosbuvir against COVID-19 neurological symptoms PLOSBiology UCSanDiego COVID19 coronavirus covid symptoms neurology
Lire la suite »
China’s Covid protests grow after apartment blaze kills 10\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Lire la suite »